The role of RUNX2 in osteosarcoma oncogenesis

Sarcoma

Volumn 2011, Issue , 2011, Pages

  Squire, J A ^a   Martin, J W ^a   Zielenska, M ^b   Stein, G S ^c   Van Wijnen, A J ^c  

^a QUEEN S UNIVERSITY   (Canada)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

^c UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR RUNX1; TRANSCRIPTION FACTOR RUNX2; TRANSCRIPTION FACTOR RUNX3;

BONE DEVELOPMENT; CANCER DIAGNOSIS; CARCINOGENESIS; CHONDROGENESIS; CHROMOSOME TRANSLOCATION; GENE OVEREXPRESSION; HUMAN; NONHUMAN; OSTEOBLAST; OSTEOSARCOMA; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION; STRUCTURE ACTIVITY RELATION; TRANSCRIPTION REGULATION;

EID: 79251553733     PISSN: 1357714X     EISSN: 13691643     Source Type: Journal    
DOI: 10.1155/2011/282745     Document Type: Review

References (174)

1. Raymond A. K., Ayala A. G., Knuutila S., Unni K. K., Mertens F., Conventional osteosarcoma Pathology and Genetics of Tumours of Soft Tissue and Bone, Fletcher CDM 2002 Lyon, France IARC Press 264 270
2. Bielack S. S., Kempf-Bielack B., Delling G., Exner G. U., Flege S., Helmke K., Kotz R., Salzer-Kuntschik M., Wemer M., Winkelmann W., Zoubek A., Jörgens H., Winkler K., Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols Journal of Clinical Oncology 2002 20 3 776 790
3. Longhi A., Errani C., De Paolis M., Mercuri M., Bacci G., Primary bone osteosarcoma in the pediatric age: state of the art Cancer Treatment Reviews 2006 32 6 423 436
4. Jaffe N., Osteosarcoma: review of the past, impact on the future. The American experience Cancer Treatment and Research 2009 152 239 262
5. Bacci G., Ferrari S., Longhi A., Perin S., Forni C., Fabbri N., Salduca N., Versari M., Smith K. V. J., Pattern of relapse in patients with osteosarcoma of the extremities treated with neoadjuvant chemotherapy European Journal of Cancer 2001 37 1 32 38
6. Kansara M., Thomas D. M., Molecular pathogenesis of osteosarcoma DNA and Cell Biology 2007 26 1 1 18
7. Hansen M. F., Koufos A., Gallie B. L., Osteosarcoma and retinoblastoma: a shared chromosomal mechanism revealing recessive predisposition Proceedings of the National Academy of Sciences of the United States of America 1985 82 18 6216 6220
8. Fuchs B., Pritchard D. J., Etiology of osteosarcoma Clinical Orthopaedics and Related Research 2002 397 40 52
9. Malkin D., Li F. P., Strong L. C., Fraumeni J. F. Jr. , Nelson C. E., Kim D. H., Kassel J., Gryka M. A., Bischoff F. Z., Tainsky M. A., Friend S. H., Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms Science 1990 250 4985 1233 1238
10. Maire G., Yoshimoto M., Chilton-MacNeill S., Thorner P. S., Zielenska M., Squire J. A., Recurrent RECQL4 imbalance and increased gene expression levels are associated with structural chromosomal instability in sporadic osteosarcoma Neoplasia 2009 11 3 260 268
11. Lau C. C., Harris C. P., Lu X.-Y., Perlaky L., Gogineni S., Chintagumpala M., Hicks J., Johnson M. E., Davino N. A., Huvos A. G., Meyers P. A., Healy J. H., Gorlick R., Rao P. H., Frequent amplification and rearrangement of chromosomal bands 6p12-p21 and 17p11.2 in osteosarcoma Genes Chromosomes and Cancer 2004 39 1 11 21
12. Lu X.-Y., Lu Y., Zhao Y.-J., Jaeweon K., Kang J., Li X.-N., Ge G., Meyer R., Perlaky L., Hicks J., Chintagumpala M., Cai W.-W., Ladanyi M., Gorlick R., Lau C. C., Pati D., Sheldon M., Rao P. H., Cell cycle regulator gene CDC5L, a potential target for 6p12-p21 amplicon in osteosarcoma Molecular Cancer Research 2008 6 6 937 946
13. Man T.-K., Lu X.-Y., Jaeweon K., Perlaky L., Harris C. P., Shah S., Ladanyi M., Gorlick R., Lau C. C., Rao P. H., Genome-wide array comparative genomic hybridization analysis reveals distinct amplifications in osteosarcoma BMC Cancer 2004 4, article 45
14. Smida J., Baumhoer D., Rosemann M., Walch A., Bielack S., Poremba C., Remberger K., Korsching E., Scheurlen W., Dierkes C., Burdach S., Jundt G., Atkinson M. J., Nathrath M., Genomic alterations and allelic imbalances are strong prognostic predictors in osteosarcoma Clinical Cancer Research 2010 16 16 4256 4267
15. Squire J. A., Pei J., Marrano P., Beheshti B., Bayani J., Lim G., Moldovan L., Zielenska M., High-resolution mapping of amplifications and deletions in pediatric osteosarcoma by use of CGH analysis of cDNA microarrays Genes Chromosomes and Cancer 2003 38 3 215 225
16. Zielenska M., Bayani J., Pandita A., Toledo S., Marrano P., Andrade J., Petrilli A., Thorner P., Sorensen P., Squire J. A., Comparative genomic hybridization analysis identifies gains of 1p35 p36 and chromosome 19 in osteosarcoma Cancer Genetics and Cytogenetics 2001 130 1 14 21
17. Zielenska M., Marrano P., Thorner P., Pei J., Beheshti B., Ho M., Bayani J., Liu Y., Sun B. C., Squire J. A., Haod X.-S., High-resolution cDNA microarray CGH mapping of genomic imbalances in osteosarcoma using formalin-fixed paraffin-embedded tissue Cytogenetic and Genome Research 2004 107 1-2 77 82
18. Selvarajah S., Yoshimoto M., Ludkovski O., Park P. C., Bayani J., Thorner P., Maire G., Squire J. A., Zielenska M., Genomic signatures of chromosomal instability and osteosarcoma progression detected by high resolution array CGH and interphase FISH Cytogenetic and Genome Research 2008 122 1 5 15
19. Selvarajah S., Yoshimoto M., Maire G., Paderova J., Bayani J., Squire J. A., Zielenska M., Identification of cryptic microaberrations in osteosarcoma by high-definition oligonucleotide array comparative genomic hybridization Cancer Genetics and Cytogenetics 2007 179 1 52 61
20. Selvarajah S., Yoshimoto M., Park P. C., Maire G., Paderova J., Bayani J., Lim G., Al-Romaih K., Squire J. A., Zielenska M., The breakage-fusion-bridge (BFB) cycle as a mechanism for generating genetic heterogeneity in osteosarcoma Chromosoma 2006 115 6 459 467
21. Sadikovic B., Yoshimoto M., Al-Romaih K., Maire G., Zielenska M., Squire J. A., In vitro analysis of integrated global high-resolution DNA methylation profiling with genomic imbalance and gene expression in osteosarcoma PLoS ONE 2008 3 7
22. Forus A., Weghuis D. O., Smeets D., Fodstad O., Myklebost O., Van Kessel A. G., Comparative genomic hybridization analysis of human sarcomas: II. Identification of novel amplicons at 6p and 17p in osteosarcomas Genes Chromosomes and Cancer 1995 14 1 15 21
23. Sadikovic B., Thorner P., Chilton-MacNeill S., Martin J. W., Cervigne N. K., Squire J., Zielenska M., Expression analysis of genes associated with human osteosarcoma tumors shows correlation of RUNX2 overexpression with poor response to chemotherapy BMC Cancer 2010 10, article 202
24. Galindo M., Pratap J., Young D. W., Hovhannisyan H., Im H.-J., Choi J.-Y., Lian J. B., Stein J. L., Stein G. S., Van Wijnen A. J., The bone-specific expression of Runx2 oscillates during the cell cycle to support a G1-related antiproliferative function in osteoblasts Journal of Biological Chemistry 2005 280 21 20274 20285
25. Nathan S. S., Pereira B. P., Zhou Y.-F., Gupta A., Dombrowski C., Soong R., Pho R. W. H., Stein G. S., Salto-Tellez M., Cool S. M., Van Wijnen A. J., Elevated expression of Runx2 as a key parameter in the etiology of osteosarcoma Molecular Biology Reports 2009 36 1 153 158
26. Pereira B. P., Zhou Y., Gupta A., Leong D. T., Aung K. Z., Ling L., Pho R. W., Galindo M., Salto-Tellez M., Stein G. S., Cool S. M., van Wijnen A. J., Nathan S. S., Runx2, p53, and pRB status as diagnostic parameters for deregulation of osteoblast growth and differentiation in a new pre-chemotherapeutic osteosarcoma cell line (OS1) Journal of Cellular Physiology 2009 221 3 778 788
27. San Martin I. A., Varela N., Gaete M., Villegas K., Osorio M., Tapia J. C., Antonelli M., Mancilla E. E., Pereira B. P., Nathan S. S., Lian J. B., Stein J. L., Stein G. S., van Wijnen A. J., Galindo M., Impaired cell cycle regulation of the osteoblast-related heterodimeric transcription factor Runx2-Cbfbeta in osteosarcoma cells Journal of Cellular Physiology 2009 221 3 560 571
28. Levanon D., Negreanu V., Bernstein Y., Bar-Am I., Avivi L., Groner Y., AML1, AML2, and AML3, the human members of the runt domain gene-family: cDNA structure, expression, and chromosomal localization Genomics 1994 23 2 425 432
29. van Wijnen A. J., Stein G. S., Gergen J. P., Groner Y., Hiebert S. W., Ito Y., Liu P., Neil J. C., Ohki M., Speck N., Nomenclature for Runt-related (RUNX) proteins Oncogene 2004 23 24 4209 4210
30. Kagoshima H., Shigesada K., Kohara Y., RUNX regulates stem cell proliferation and differentiation: insights from studies of C. elegans Journal of Cellular Biochemistry 2007 100 5 1119 1130
31. Lutterbach B., Hiebert S. W., Role of the transcription factor AML-1 in acute leukemia and hematopoietic differentiation Gene 2000 245 2 223 235
32. Okuda T., Van Deursen J., Hiebert S. W., Grosveld G., Downing J. R., AML1, the target of multiple chromosomal translocations in human leukemia, is essential for normal fetal liver hematopoiesis Cell 1996 84 2 321 330
33. Wang Q., Stacy T., Binder M., Marn-Padilla M., Sharpe A. H., Speck N. A., Disruption of the Cbfa2 gene causes necrosis and hemorrhaging in the central nervous system and blocks definitive hematopoiesis Proceedings of the National Academy of Sciences of the United States of America 1996 93 8 3444 3449
34. Inoue K.-I., Ito K., Osato M., Lee B., Bae S.-C., Ito Y., The transcription factor Runx3 represses the neurotrophin receptor TrkB during lineage commitment of dorsal root ganglion neurons Journal of Biological Chemistry 2007 282 33 24175 24184
35. Inoue K.-I., Ozaki S., Shiga T., Ito K., Masuda T., Okado N., Iseda T., Kawaguchi S., Ogawa M., Bae S.-C., Yamashita N., Itohara S., Kudo N., Ito Y., Runx3 controls the axonal projection of proprioceptive dorsal root ganglion neurons Nature Neuroscience 2002 5 10 946 954
36. Li Q.-L., Ito K., Sakakura C., Fukamachi H., Inoue K.-I., Chi X.-Z., Lee K.-Y., Nomura S., Lee C.-W., Han S.-B., Kim H.-M., Kim W.-J., Yamamoto H., Yamashita N., Yano T., Ikeda T., Itohara S., Inazawa J., Abe T., Hagiwara A., Yamagishi H., Ooe A., Kaneda A., Sugimura T., Ushijima T., Bae S.-C., Ito Y., Causal relationship between the loss of RUNX3 expression and gastric cancer Cell 2002 109 1 113 124
37. Ito K., Liu Q., Salto-Tellez M., Yano T., Tada K., Ida H., Huang C., Shah N., Inoue M., Rajnakova A., Hiong K. C., Peh B. K., Han H. C., Ito T., Teh M., Yeoh K. G., Ito Y., RUNX3, a novel tumor suppressor, is frequently inactivated in gastric cancer by protein mislocalization Cancer Research 2005 65 17 7743 7750
38. Komori T., Yagi H., Nomura S., Yamaguchi A., Sasaki K., Deguchi K., Shimizu Y., Bronson R. T., Gao Y.-H., Inada M., Sato M., Okamoto R., Kitamura Y., Yoshiki S., Kishimoto T., Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts Cell 1997 89 5 755 764
39. Otto F., Thornell A. P., Crompton T., Denzel A., Gilmour K. C., Rosewell I. R., Stamp G. W. H., Beddington R. S. P., Mundlos S., Olsen B. R., Selby P. B., Owen M. J., Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development Cell 1997 89 5 765 771
40. Komori T., Regulation of bone development and extracellular matrix protein genes by RUNX2 Cell and Tissue Research 2010 339 1 189 195
41. Geoffroy V., Corral D. A., Zhou L., Lee B., Karsenty G., Genomic organization, expression of the human CBFA1 gene, and evidence for an alternative splicing event affecting protein function Mammalian Genome 1998 9 1 54 57
42. Makita N., Suzuki M., Asami S., Takahata R., Kohzaki D., Kobayashi S., Hakamazuka T., Hozumi N., Two of four alternatively spliced isoforms of RUNX2 control osteocalcin gene expression in human osteoblast cells Gene 2008 413 1-2 8 17
43. Xiao Z. S., Thomas R., Hinson T. K., Quarles L. D., Genomic structure and isoform expression of the mouse, rat and human Cbfa1/Osf2 transcription factor Gene 1998 214 1-2 187 197
44. Terry A., Kilbey A., Vaillant F., Stewart M., Jenkins A., Cameron E., Neil J. C., Conservation and expression of an alternative 3′ exon of Runx2 encoding a novel proline-rich C-terminal domain Gene 2004 336 1 115 125
45. Lian J. B., Javed A., Zaidi S. K., Lengner C., Montecino M., Van Wijnen A. J., Stein J. L., Stein G. S., Regulatory controls for osteoblast growth and differentiation: role of Runx/Cbfa/AML factors Critical Reviews in Eukaryotic Gene Expression 2004 14 1-2 1 41
46. Thirunavukkarasu K., Mahajan M., McLarren K. W., Stifani S., Karsenty G., Two domains unique to osteoblast-specific transcription factor Osf2/Cbfa1 contribute to its transactivation function and its inability to heterodimerize with Cbf Molecular and Cellular Biology 1998 18 7 4197 4208
47. Javed A., Guo B., Hiebert S., Choi J.-Y., Green J., Zhao S.-C., Osborne M. A., Stifani S., Stein J. L., Lian J. B., Van Wijnen A. J., Stein G. S., Groucho/TLE/R-esp proteins associate with the nuclear matrix and repress RUNX (CBF /AML/PEBP2 ) dependent activation of tissue-specific gene transcription Journal of Cell Science 2000 113 12 2221 2231
48. Levanon D., Goldstein R. E., Bernstein Y., Tang H., Goldenberg D., Stifan S., Paroush Z., Groner Y., Transcriptional repression by AML1 and LEF-1 is mediated by the TLE/Groucho corepressors Proceedings of the National Academy of Sciences of the United States of America 1998 95 20 11590 11595
49. Drissi H., Luc Q., Shakoori R., De Sousa Lopes S. C., Choi J.-Y., Terry A., Hu M., Jones S., Neil J. C., Lian J. B., Stein J. L., Van Wijnen A. J., Stein G. S., Transcriptional autoregulation of the bone related CBFA1/RUNX2 gene Journal of Cellular Physiology 2000 184 3 341 350
50. Stock M., Otto F., Control of RUNX2 isoform expression: the role of promoters and enhancers Journal of Cellular Biochemistry 2005 95 3 506 517
51. Kagoshima H., Shigesada K., Satake M., Ito Y., Miyoshi H., Ohki M., Pepling M., Gergen P., The Runt domain identifies a new family of heteromeric transcriptional regulators Trends in Genetics 1993 9 10 338 341
52. Canon J., Banerjee U., Runt and Lozenge function in Drosophila development Seminars in Cell and Developmental Biology 2000 11 5 327 336
53. Ogawa E., Maruyama M., Kagoshima H., Inuzuka M., Lu J., Satake M., Shigesada K., Ito Y., PEBP2/PEA2 represents a family of transcription factors homologous to the products of the Drosophila runt gene and the human AML1 gene Proceedings of the National Academy of Sciences of the United States of America 1993 90 14 6859 6863
54. Miller J., Horner A., Stacy T., Lowrey C., Lian J. B., Stein G., Nuckolls G. H., Speck N. A., The core-binding factor subunit is required for bone formation and hematopoietic maturation Nature Genetics 2002 32 4 645 649
55. Ogawa E., Inuzuka M., Maruyama M., Satake M., Naito-Fujimoto M., Ito Y., Shigesada K., Molecular cloning and characterization of PEBP2, the heterodimeric partner of a novel Drosophila runt-related DNA binding protein PEBP2 Virology 1993 194 1 314 331
56. Satake M., Nomura S., Yamaguchi-Iwai Y., Takahama Y., Hashimoto Y., Niki M., Kitamura Y., Ito Y., Expression of the Runt domain-encoding PEBP2 genes in T cells during thymic development Molecular and Cellular Biology 1995 15 3 1662 1670
57. Lengner C. J., Drissi H., Choi J.-Y., Van Wijnen A. J., Stein J. L., Stein G. S., Lian J. B., Activation of the bone-related Runx2/Cbfa1 promoter in mesenchymal condensations and developing chondrocytes of the axial skeleton Mechanisms of Development 2002 114 1-2 167 170
58. Mundlos S., Mulliken J. B., Abramson D. L., Warman M. L., Knoll J. H. M., Olsen B. R., Genetic mapping of cleidocranial dysplasia and evidence of a microdeletion in one family Human Molecular Genetics 1995 4 1 71 75
59. Ramesar R. S., Greenberg J., Martin R., Goliath R., Bardien S., Mundlos S., Beighton P., Mapping of the gene for cleidocranial dysplasia in the historical Cape Town (Arnold) kindred and evidence for locus homogeneity Journal of Medical Genetics 1996 33 6 511 514
60. Mundlos S., Otto F., Mundlos C., Mulliken J. B., Aylsworth A. S., Albright S., Lindhout D., Cole W. G., Henn W., Knoll J. H. M., Owen M. J., Mertelsmann R., Zabel B. U., Olsen B. R., Mutations involving the transcription factor CBFA1 cause cleidocranial dysplasia Cell 1997 89 5 773 779
61. Quack I., Vonderstrass B., Stock M., Aylsworth A. S., Becker A., Brueton L., Lee P. J., Majewski F., Mulliken J. B., Suri M., Zenker M., Mundlos S., Otto F., Mutation analysis of core binding factor A1 in patients with cleidocranial dysplasia American Journal of Human Genetics 1999 65 5 1268 1278
62. Choi J.-Y., Pratap J., Javed A., Zaidi S. K., Xing L., Balint E., Dalamangas S., Boyce B., Van Wijnen A. J., Lian J. B., Stein J. L., Jones S. N., Stein G. S., Subnuclear targeting of Runx/CBFa/AML factors is essential for tissue-specific differentiation during embryonic development Proceedings of the National Academy of Sciences of the United States of America 2001 98 15 8650 8655
63. Lou Y., Javed A., Hussain S., Colby J., Frederick D., Pratap J., Xie R., Gaur T., van Wijnen A. J., Jones S. N., Stein G. S., Lian J. B., Stein J. L., A Runx2 threshold for the cleidocranial dysplasia phenotype Human Molecular Genetics 2009 18 3 556 568
64. Banerjee C., Hiebert S. W., Stein J. L., Lian J. B., Stein G. S., An AML-1 consensus sequence binds an osteoblast-specific complex and transcriptionally activates the osteocalcin gene Proceedings of the National Academy of Sciences of the United States of America 1996 93 10 4968 4973
65. Merriman H. L., Van Wijnen A. J., Hiebert S., Bidwell J. P., Fey E., Lian J., Stein J., Stein G. S., The tissue-specific nuclear matrix protein, NMP-2, is a member of the AML/CBF/PEBP2/runt domain transcription factor family: interactions with the osteocalcin gene promoter Biochemistry 1995 34 40 13125 13132
66. Stein G. S., Lian J. B., van Wijnen A. J., Stein J. L., Montecino M., Javed A., Zaidi S. K., Young D. W., Choi J.-Y., Pockwinse S. M., Runx2 control of organization, assembly and activity of the regulatory machinery for skeletal gene expression Oncogene 2004 23 24 4315 4329
67. Geoffroy V., Kneissel M., Fournier B., Boyde A., Matthias P., High bone resorption in adult aging transgenic mice overexpressing Cbfa1/Runx2 in cells of the osteoblastic lineage Molecular and Cellular Biology 2002 22 17 6222 6233
68. Takeda S., Bonnamy J.-P., Owen M. J., Ducy P., Karsenty G., Continuous expression of Cbfa1 in nonhypertrophic chondrocytes uncovers its ability to induce hypertrophic chondrocyte differentiation and partially rescues Cbfa1-deficient mice Genes and Development 2001 15 4 467 481
69. Yoshida C. A., Komori T., Role of Runx proteins in chondrogenesis Critical Reviews in Eukaryotic Gene Expression 2005 15 3 243 254
70. Zhou G., Zheng Q., Engin F., Munivez E., Chen Y., Sebald E., Krakow D., Lee B., Dominance of SOX9 function over RUNX2 during skeletogenesis Proceedings of the National Academy of Sciences of the United States of America 2006 103 50 19004 19009
71. Long F., Chung U.-I., Ohba S., McMahon J., Kronenberg H. M., McMahon A. P., Ihh signaling is directly required for the osteoblast lineage in the endochondral skeleton Development 2004 131 6 1309 1318
72. Rodda S. J., McMahon A. P., Distinct roles for Hedgehog and caronical Wnt signaling in specification, differentiation and maintenance of osteoblast progenitors Development 2006 133 16 3231 3244
73. Yoshida C. A., Yamamoto H., Fujita T., Furuichi T., Ito K., Inoue K.-I., Yamana K., Zanma A., Takada K., Ito Y., Komori T., Runx2 and Runx3 are essential for chondrocyte maturation, and Runx2 regulates limb growth through induction of Indian hedgehog Genes and Development 2004 18 8 952 963
74. Mukherjee A., Wilson E. M., Rotwein P., Selective signaling by Akt2 promotes bone morphogenetic protein 2-mediated osteoblast differentiation Molecular and Cellular Biology 2010 30 4 1018 1027
75. Ling L., Dombrowski C., Foong K. M., Haupt L. M., Stein G. S., Nurcombe V., Van Wijnen A. J., Cool S. M., Synergism between Wnt3a and heparin enhances osteogenesis via a phosphoinositide 3-kinase/Akt/RUNX2 pathway Journal of Biological Chemistry 2010 285 34 26233 26244
76. Gaur T., Lengner C. J., Hovhannisyan H., Bhat R. A., Bodine P. V. N., Komm B. S., Javed A., Van Wijnen A. J., Stein J. L., Stein G. S., Lian J. B., Canonical WNT signaling promotes osteogenesis by directly stimulating Runx2 gene expression Journal of Biological Chemistry 2005 280 39 33132 33140
77. Hill T. P., Spter D., Taketo M. M., Birchmeier W., Hartmann C., Canonical Wnt/ -catenin signaling prevents osteoblasts from differentiating into chondrocytes Developmental Cell 2005 8 5 727 738
78. Zhang Y., Hassan M. Q., Xie R.-L., Hawse J. R., Spelsberg T. C., Montecino M., Stein J. L., Lian J. B., Van Wijnen A. J., Stein G. S., Co-stimulation of the bone-related Runx2 P1 promoter in mesenchymal cells by SP1 and ETS transcription factors at polymorphic purine-rich DNA sequences (Y-repeats) Journal of Biological Chemistry 2009 284 5 3125 3135
79. Hassan M. Q., Tare R. S., Lee S. H., Mandeville M., Morasso M. I., Javed A., Van Wijnen A. J., Stein J. L., Stein G. S., Lian J. B., BMP2 commitment to the osteogenic lineage involves activation of Runx2 by DLX3 and a homeodomain transcriptional network Journal of Biological Chemistry 2006 281 52 40515 40526
80. Kanno T., Takahashi T., Tsujisawa T., Ariyoshi W., Nishihara T., Mechanical stress-mediated Runx2 activation is dependent on Ras/ERK1/2 MAPK signaling in osteoblasts Journal of Cellular Biochemistry 2007 101 5 1266 1277
81. Ziros P. G., Gil A.-P. R., Georgakopoulos T., Habeos I., Kletsas D., Basdra E. K., Papavassiliou A. G., The bone-specific transcriptional regulator Cbfa1 is a target of mechanical signals in osteoblastic cells Journal of Biological Chemistry 2002 277 26 23934 23941
82. Kim H.-J., Kim J.-H., Bae S.-C., Choi J.-Y., Kim H.-J., Ryoo H.-M., The protein kinase C pathway plays a central role in the fibroblast growth factor-stimulated expression and transactivation activity of Runx2 Journal of Biological Chemistry 2003 278 1 319 326
83. Drissi H., Pouliot A., Koolloos C., Stein J. L., Lian J. B., Stein G. S., Van Wijnen A. J., 1,25- (OH)2 -vitamin D3 suppresses the bone-related Runx2/Cbfa1 gene promoter Experimental Cell Research 2002 274 2 323 333
84. Lecka-Czernik B., Gubrij I., Moerman E. J., Kajkenova O., Lipschitz D. A., Manolagas S. C., Jilka R. L., Inhibition of Osf2/Cbfa1 expression and terminal osteoblast differentiation by PPAR 2 Journal of Cellular Biochemistry 1999 74 3 357 371
85. Gilbert L., He X., Farmer P., Rubin J., Drissi H., Van Wijnen A. J., Lian J. B., Stein G. S., Nanes M. S., Expression of the osteoblast differentiation factor RUNX2 (Cbfa1/AML3/Pebp2 A) is inhibited by tumor necrosis factor- Journal of Biological Chemistry 2002 277 4 2695 2701
86. Yamashita S., Andoh M., Ueno-Kudoh H., Sato T., Miyaki S., Asahara H., Sox9 directly promotes Bapx1 gene expression to repress Runx2 in chondrocytes Experimental Cell Research 2009 315 13 2231 2240
87. Lengner C. J., Hassan M. Q., Serra R. W., Lepper C., Van Wijnen A. J., Stein J. L., Lian J. B., Stein G. S., Nkx3.2-mediated repression of Runx2 promotes chondrogenic differentiation Journal of Biological Chemistry 2005 280 16 15872 15879
88. Tintutt Y., Parhami F., Le V., Karsenty G., Demer L. L., Inhibition of osteoblast-specific transcription factor Cbfa1 by the cAMP pathway in osteoblastic cells. Ubiquitin/proteasome-dependent regulation Journal of Biological Chemistry 1999 274 41 28875 28879
89. Rajgopal A., Young D. W., Mujeeb K. A., Stein J. L., Lian J. B., Van Wijnen A. J., Stein G. S., Mitotic control of RUNX2 phosphorylation by both CDK1/cyclin B kinase and PP1/PP2A phosphatase in osteoblastic cells Journal of Cellular Biochemistry 2007 100 6 1509 1517
90. Li X., Hoeppner L. H., Jensen E. D., Gopalakrishnan R., Westendorf J. J., Co-activator activator (CoAA) prevents the transcriptional activity of runt domain transcription factors Journal of Cellular Biochemistry 2009 108 2 378 387
91. Jeon E.-J., Lee K.-Y., Choi N.-S., Lee M.-H., Kim H.-N., Jin Y.-H., Ryoo H.-M., Choi J.-Y., Yoshida M., Nishino N., Oh B.-C., Lee K.-S., Yong H. L., Bae S.-C., Bone morphogenetic protein-2 stimulates Runx2 acetylation Journal of Biological Chemistry 2006 281 24 16502 16511
92. Jemtland R., Divieti P., Lee K., Segre G. V., Hedgehog promotes primary osteoblast differentiation and increases PTHrP mRNA expression and iPTHrP secretion Bone 2003 32 6 611 620
93. Spinella-Jaegle S., Rawadi G., Kawai S., Gallea S., Faucheu C., Mollat P., Courtois B., Bergaud B., Ramez V., Blanchet A. M., Adelmant G., Baron R., Roman-Roman S., Sonic hedgehog increases the commitment of pluripotent mesenchymal cells into the osteoblastic lineage and abolishes adipocytic differentiation Journal of Cell Science 2001 114 11 2085 2094
94. Zhou H., Mak W., Zheng Y., Dunstan C. R., Seibel M. J., Osteoblasts directly control lineage commitment of mesenchymal progenitor cells through Wnt signaling Journal of Biological Chemistry 2008 283 4 1936 1945
95. Reinhold M. I., Naski M. C., Direct interactions of Runx2 and canonical Wnt signaling induce FGF18 Journal of Biological Chemistry 2007 282 6 3653 3663
96. Ohbayashi N., Shibayama M., Kurotaki Y., Imanishi M., Fujimori T., Itoh N., Takada S., FGF18 is required for normal cell proliferation and differentiation during osteogenesis and chondrogenesis Genes and Development 2002 16 7 870 879
97. Nishio Y., Dong Y., Paris M., O'Keefe R. J., Schwarz E. M., Drissi H., Runx2-mediated regulation of the zinc finger Osterix/Sp7 gene Gene 2006 372 1-2 62 70
98. Bais M. V., Wigner N., Young M., Toholka R., Graves D. T., Morgan E. F., Gerstenfeld L. C., Einhorn T. A., BMP2 is essential for post natal osteogenesis but not for recruitment of osteogenic stem cells Bone 2009 45 2 254 266
99. Matsubara T., Kida K., Yamaguchi A., Hata K., Ichida F., Meguro H., Aburatani H., Nishimura R., Yoneda T., BMP2 regulates osterix through Msx2 and Runx2 during osteoblast differentiation Journal of Biological Chemistry 2008 283 43 29119 29125
100. Javed A., Bae J.-S., Afza F., Gutierrez S., Pratap J., Zaidi S. K., Lou Y., Van Wijnen A. J., Stein J. L., Stein G. S., Lian J. B., Structural coupling of Smad and Runx2 for execution of the BMP2 osteogenic signal Journal of Biological Chemistry 2008 283 13 8412 8422
101. Kato M., Patel M. S., Levasseur R., Lobov I., Chang B. H.-J., Glass D. A. II, Hartmann C., Li L., Hwang T.-H., Brayton C. F., Lang R. A., Karsenty G., Chan L., Cbfa1-independent decrease in osteoblast proliferation, osteopenia, and persistent embryonic eye vascularization in mice deficient in Lrp5, a Wnt coreceptor Journal of Cell Biology 2002 157 2 303 314
102. Rawadi G., Vayssire B., Dunn F., Baron R., Roman-Roman S., BMP-2 controls alkaline phosphatase expression and osteoblast mineralization by a Wnt autocrine loop Journal of Bone and Mineral Research 2003 18 10 1842 1853
103. Almeida M., Han L., Bellido T., Manolagas S. C., Kousteni S., Wnt proteins prevent apoptosis of both uncommitted osteoblast progenitors and differentiated osteoblast by -catenin-dependent and -independent signaling cascades involving Src/ERK and phosphatidylinositol 3-kinase/AKT Journal of Biological Chemistry 2005 280 50 41342 41351
104. Pratap J., Galindo M., Zaidi S. K., Vradii D., Bhat B. M., Robinson J. A., Choi J.-Y., Komori T., Stein J. L., Lian J. B., Stein G. S., Van Wijnen A. J., Cell growth regulatory role of Runx2 during proliferative expansion of preosteoblasts Cancer Research 2003 63 17 5357 5362
105. Young D. W., Hassan M. Q., Pratap J., Galindo M., Zaidi S. K., Lee S.-H., Yang X., Xie R., Javed A., Underwood J. M., Furcinitti P., Imbalzano A. N., Penman S., Nickerson J. A., Montecino M. A., Lian J. B., Stein J. L., Van Wijnen A. J., Stein G. S., Mitotic occupancy and lineage-specific transcriptional control of rRNA genes by Runx2 Nature 2007 445 7126 442 446
106. Young D. W., Hassan M. Q., Yang X.-Q., Galindo M., Javed A., Zaidi S. K., Furcinitti P., Lapointe D., Montecino M., Lian J. B., Stein J. L., Van Wijnen A. J., Stein G. S., Mitotic retention of gene expression patterns by the cell fate-determining transcription factor Runx2 Proceedings of the National Academy of Sciences of the United States of America 2007 104 9 3189 3194
107. Zaidi S. K., Young D. W., Montecino M. A., Lian J. B., Van Wijnen A. J., Stein J. L., Stein G. S., Mitotic bookmarking of genes: a novel dimension to epigenetic control Nature Reviews Genetics 2010 11 8 583 589
108. Eliseev R. A., Dong Y.-F., Sampson E., Zuscik M. J., Schwarz E. M., O'Keefe R. J., Rosier R. N., Drissi M. H., Runx2-mediated activation of the Bax gene increases osteosarcoma cell sensitivity to apoptosis Oncogene 2008 27 25 3605 3614
109. Teplyuk N. M., Galindo M., Teplyuk V. I., Pratap J., Young D. W., Lapointe D., Javed A., Stein J. L., Lian J. B., Stein G. S., Van Wijnen A. J., Runx2 regulates G protein-coupled signaling pathways to control growth of osteoblast progenitors Journal of Biological Chemistry 2008 283 41 27585 27597
110. Westendorf J. J., Zaidi S. K., Cascino J. E., Kahler R., Van Wijnen A. J., Lian J. B., Yoshida M., Stein G. S., Li X., Runx2 (Cbfa1, AML-3) interacts with histone deacetylase 6 and represses the p21CIP1/WAF1 promoter Molecular and Cellular Biology 2002 22 22 7982 7992
111. Ho W.-P., Chan W.-P., Hsieh M.-S., Chen R.-M., Runx2-mediated bcl-2 gene expression contributes to nitric oxide protection against hydrogen peroxide-induced osteoblast apoptosis Journal of Cellular Biochemistry 2009 108 5 1084 1093
112. Zaragoza C., López-Rivera E., Garca-Rama C., Saura M., Martnez-Ruz A., Lizarbe T. R., Martn-de-Lara F., Lamas S., Cbfa-1 mediates nitric oxide regulation of MMP-13 in osteoblasts Journal of Cell Science 2006 119 9 1896 1902
113. Ortega N., Behonick D. J., Werb Z., Matrix remodeling during endochondral ossification Trends in Cell Biology 2004 14 2 86 93
114. Fujita T., Azuma Y., Fukuyama R., Hattori Y., Yoshida C., Koida M., Ogita K., Komori T., Runx2 induces osteoblast and chondrocyte differentiation and enhances their migration by coupling with PI3K-Akt signaling Journal of Cell Biology 2004 166 1 85 95
115. Fukuyama R., Fujita T., Azuma Y., Hirano A., Nakamuta H., Koida M., Komori T., Statins inhibit osteoblast migration by inhibiting Rac-Akt signaling Biochemical and Biophysical Research Communications 2004 315 3 636 642
116. Hughes F. J., Aubin J. E., Heersche J. N. M., Differential chemotactic responses of different populations of fetal rat calvaria cells to platelet-derived growth factor and transforming growth factor Bone and Mineral 1992 19 1 63 74
117. Panagakos F. S., Insulin-like growth factors-I and -II stimulate chemotaxis of osteoblasts isolated from fetal rat calvaria Biochimie 1993 75 11 991 994
118. Thomas D. M., Johnson S. A., Sims N. A., Trivett M. K., Slavin J. L., Rubin B. P., Waring P., McArthur G. A., Walkley C. R., Holloway A. J., Diyagama D., Grim J. E., Clurman B. E., Bowtell D. D. L., Lee J.-S., Gutierrez G. M., Piscopo D. M., Carty S. A., Hinds P. W., Terminal osteoblast differentiation, mediated by runx2 and p27 KIP1, is disrupted in osteosarcoma Journal of Cell Biology 2004 167 5 925 934
119. Berman S. D., Calo E., Landman A. S., Danielian P. S., Miller E. S., West J. C., Fonhoue B. D., Caron A., Bronson R., Bouxsein M. L., Mukherjee S., Lees J. A., Metastatic osteosarcoma induced by inactivation of Rb and p53 in the osteoblast lineage Proceedings of the National Academy of Sciences of the United States of America 2008 105 33 11851 11856
120. Lee J.-S., Thomas D. M., Gutierrez G., Carty S. A., Yanagawa S.-I., Hinds P. W., HES1 cooperates with pRb to activate RUNX2-dependent transcription Journal of Bone and Mineral Research 2006 21 6 921 933
121. Thomas D. M., Carty S. A., Piscopo D. M., Lee J.-S., Wang W.-F., Forrester W. C., Hinds P. W., The retinoblastoma protein acts as a transcriptional coactivator required for osteogenic differentiation Molecular Cell 2001 8 2 303 316
122. Sierra J., Villagra A., Paredes R., Cruzat F., Gutierrez S., Javed A., Arriagada G., Olate J., Imschenetzky M., Van Wijnen A. J., Lian J. B., Stein G. S., Stein J. L., Montecino M., Regulation of the bone-specific osteocalcin gene by p300 requires Runx2/Cbfa1 and the vitamin D3 receptor but not p300 intrinsic histone acetyltransferase activity Molecular and Cellular Biology 2003 23 9 3339 3351
123. Pelletier N., Champagne N., Stifani S., Yang X.-J., MOZ and MORF histone acetyltransferases interact with the Runt-domain transcription factor Runx2 Oncogene 2002 21 17 2729 2740
124. Schroeder T. M., Kahler R. A., Li X., Westendorf J. J., Histone deacetylase 3 interacts with Runx2 to repress the osteocalcin promoter and regulate osteoblast differentiation Journal of Biological Chemistry 2004 279 40 41998 42007
125. Westendorf J. J., Transcriptional co-repressors of Runx2 Journal of Cellular Biochemistry 2006 98 1 54 64
126. Zaidi S. K., Sullivan A. J., Medina R., Ito Y., Van Wijnen A. J., Stein J. L., Lian J. B., Stein G. S., Tyrosine phosphorylation controls Runx2-mediated subnuclear targeting of YAP to repress transcription The EMBO Journal 2004 23 4 790 799
127. Vega R. B., Matsuda K., Oh J., Barbosa A. C., Yang X., Meadows E., McAnally J., Pomajzl C., Shelton J. M., Richardson J. A., Karsenty G., Olson E. N., Histone deacetylase 4 controls chondrocyte hypertrophy during skeletogenesis Cell 2004 119 4 555 566
128. Andela V. B., Siddiqui F., Groman A., Rosier R. N., An immunohistochemical analysis to evaluate an inverse correlation between Runx2/Cbfa1 and NF B in human osteosarcoma Journal of Clinical Pathology 2005 58 3 328 330
129. Maruyama Z., Yoshida C. A., Furuichi T., Amizuka N., Ito M., Fukuyama R., Miyazaki T., Kitaura H., Nakamura K., Fujita T., Kanatani N., Moriishi T., Yamana K., Liu W., Kawaguchi H., Nakamura K., Komori T., Runx2 determines bone maturity and turnover rate in postnatal bone development and is involved in bone loss in estrogen deficiency Developmental Dynamics 2007 236 7 1876 1890
130. Tang N., Song W.-X., Luo J., Haydon R. C., He T.-C., Osteosarcoma development and stem cell differentiation Clinical Orthopaedics and Related Research 2008 466 9 2114 2130
131. Won K. Y., Park H.-R., Park Y.-K., Prognostic implication of immunohistochemical Runx2 expression in osteosarcoma Tumori 2009 95 3 311 316
132. Kurek K. C., Del Mare S., Salah Z., Abdeen S., Sadiq H., Lee S.-H., Gaudio E., Zanesi N., Jones K. B., DeYoung B., Amir G., Gebhardt M., Warman M., Stein G. S., Stein J. L., Lian J. B., Aqeilan R. I., Frequent attenuation of the WWOX tumor suppressor in osteosarcoma is associated with increased tumorigenicity and aberrant RUNX2 expression Cancer Research 2010 70 13 5577 5586
133. Berman S. D., Yuan T. L., Miller E. S., Lee E. Y., Caron A., Lees J. A., The retinoblastoma protein tumor suppressor is important for appropriate osteoblast differentiation and bone development Molecular Cancer Research 2008 6 9 1440 1451
134. Goodrich D. W., The retinoblastoma tumor-suppressor gene, the exception that proves the rule Oncogene 2006 25 38 5233 5243
135. van Harn T., Foijer F., van Vugt M., Banerjee R., Yang F., Oostra A., Joenje H., Te Riele H., Loss of Rb proteins causes genomic instability in the absence of mitogenic signaling Genes and Development 2010 24 13 1377 1388
136. Zambetti G. P., Horwitz E. M., Schipani E., Skeletons in the p53 tumor suppressor closet: genetic evidence that p53 blocks bone differentiation and development Journal of Cell Biology 2006 172 6 795 797
137. Walkley C. R., Qudsi R., Sankaran V. G., Perry J. A., Gostissa M., Roth S. I., Rodda S. J., Snay E., Dunning P., Fahey F. H., Alt F. W., McMahon A. P., Orkin S. H., Conditional mouse osteosarcoma, dependent on p53 loss and potentiated by loss of Rb, mimics the human disease Genes and Development 2008 22 12 1662 1676
138. Lengner C. J., Steinman H. A., Gagnon J., Smith T. W., Henderson J. E., Kream B. E., Stein G. S., Lian J. B., Jones S. N., Osteoblast differentiation and skeletal development are regulated by Mdm2-p53 signaling Journal of Cell Biology 2006 172 6 909 921
139. Vidal A., Koff A., Cell-cycle inhibitors: three families united by a common cause Gene 2000 247 1-2 1 15
140. Engin F., Yao Z., Yang T., Zhou G., Bertin T., Jiang M. M., Chen Y., Wang L., Zheng H., Sutton R. E., Boyce B. F., Lee B., Dimorphic effects of Notch signaling in bone homeostasis Nature Medicine 2008 14 3 299 305
141. Shen R., Wang X., Drissi H., Liu F., O'Keefe R. J., Chen D., Cyclin D1-Cdk4 induce Runx2 ubiquitination and degradation Journal of Biological Chemistry 2006 281 24 16347 16353
142. Zhang P., Yang Y., Zweidler-McKay P. A., Hughes D. P. M., Critical role of notch signaling in osteosarcoma invasion and metastasis Clinical Cancer Research 2008 14 10 2962 2969
143. Zaidi S. K., Pande S., Pratap J., Gaur T., Grigoriu S., Ali S. A., Stein J. L., Lian J. B., Van Wijnen A. J., Stein G. S., Runx2 deficiency and defective subnuclear targeting bypass senescence to promote immortalization and tumorigenic potential Proceedings of the National Academy of Sciences of the United States of America 2007 104 50 19861 19866
144. Bailey J. M., Singh P. K., Hollingsworth M. A., Cancer metastasis facilitated by developmental pathways: sonic hedgehog, notch, and bone morphogenic proteins Journal of Cellular Biochemistry 2007 102 4 829 839
145. Dhillon A. S., Hagan S., Rath O., Kolch W., MAP kinase signalling pathways in cancer Oncogene 2007 26 22 3279 3290
146. Engin F., Bertin T., Ma O., Jiang M. M., Wang L., Sutton R. E., Donehower L. A., Lee B., Notch signaling contributes to the pathogenesis of human osteosarcomas Human Molecular Genetics 2009 18 8 1464 1470
147. Rubin E. M., Guo Y., Tu K., Xie J., Zi X., Hoang B. H., Wnt inhibitory factor 1 decreases tumorigenesis and metastasis in osteosarcoma Molecular Cancer Therapeutics 2010 9 3 731 741
148. Akech J., Wixted J. J., Bedard K., Van Der Deen M., Hussain S., Guise T. A., Van Wijnen A. J., Stein J. L., Languino L. R., Altieri D. C., Pratap J., Keller E., Stein G. S., Lian J. B., Runx2 association with progression of prostate cancer in patients: mechanisms mediating bone osteolysis and osteoblastic metastatic lesions Oncogene 2010 29 6 811 821
149. Kitazawa R., Mori K., Yamaguchi A., Kondo T., Kitazawa S., Modulation of mouse RANKL gene expression by runx2 and vitamin D 3 Journal of Cellular Biochemistry 2008 105 5 1289 1297
150. Mak K. K., Bi Y., Wan C., Chuang P.-T., Clemens T., Young M., Yang Y., Hedgehog signaling in mature osteoblasts regulates bone formation and resorption by controlling PTHrP and RANKL expression Developmental Cell 2008 14 5 674 688
151. Bendre M. S., Margulies A. G., Walser B., Akel N. S., Bhattacharrya S., Skinner R. A., Swain F., Ramani V., Mohammad K. S., Wessner L. L., Martinez A., Guise T. A., Chirgwin J. M., Gaddy D., Suva L. J., Tumor-derived interleukin-8 stimulates osteolysis independent of the receptor activator of nuclear factor- B ligand pathway Cancer Research 2005 65 23 11001 11009
152. Mori K., Le Goff B., Berreur M., Riet A., Moreau A., Blanchard F., Chevalier C., Guisle-Marsollier I., Lger J., Guicheux J., Masson M., Gouin F., Rdini F., Heymann D., Human osteosarcoma cells express functional receptor activator of nuclear factor-kappa B Journal of Pathology 2007 211 5 555 562
153. Lim M., Zhong C., Yang S., Bell A. M., Cohen M. B., Roy-Burman P., Runx2 regulates survivin expression in prostate cancer cells Laboratory Investigation 2010 90 2 222 233
154. Pratap J., Javed A., Languino L. R., Van Wijnen A. J., Stein J. L., Stein G. S., Lian J. B., The Runx2 osteogenic transcription factor regulates matrix metalloproteinase 9 in bone metastatic cancer cells and controls cell invasion Molecular and Cellular Biology 2005 25 19 8581 8591
155. van der Deen M., Akech J., Wang T., FitzGerald T. J., Altieri D. C., Languino L. R., Lian J. B., Van Wijnen A. J., Stein J. L., Stein G. S., The cancer-related Runx2 protein enhances cell growth and responses to androgen and TGF in prostate cancer cells Journal of Cellular Biochemistry 2010 109 4 828 837
156. Brubaker K. D., Vessella R. L., Brown L. G., Corey E., Prostate cancer expression of runt-domain transcription factor Runx2, a key regulator of osteoblast differentiation and function Prostate 2003 56 1 13 22
157. Barnes G. L., Hebert K. E., Kamal M., Javed A., Einhorn T. A., Lian J. B., Stein G. S., Gerstenfeld L. C., Fidelity of Runx2 activity in breast cancer cells is required for the generation of metastases-associated osteolytic disease Cancer Research 2004 64 13 4506 4513
158. Pratap J., Wixted J. J., Gaur T., Zaidi S. K., Dobson J., Gokul K. D., Hussain S., Van Wijnen A. J., Stein J. L., Stein G. S., Lian J. B., Runx2 transcriptional activation of Indian Hedgehog and a downstream bone metastatic pathway in breast cancer cells Cancer Research 2008 68 19 7795 7802
159. Blyth K., Vaillant F., Hanlon L., Mackay N., Bell M., Jenkins A., Neil J. C., Cameron E. R., Runx2 and MYC collaborate in lymphoma development by suppressing apoptotic and growth arrest pathways in vivo Cancer Research 2006 66 4 2195 2201
160. Zhang H.-Y., Jin L., Stilling G. A., Ruebel K. H., Coonse K., Tanizaki Y., Raz A., Lloyd R. V., RUNX1 and RUNX2 upregulate Galectin-3 expression in human pituitary tumors Endocrine 2009 35 1 101 111
161. Khanna C., Khan J., Nguyen P., Prehn J., Caylor J., Yeung C., Trepel J., Meltzer P., Helman L., Metastasis-associated differences in gene expression in a murine model of osteosarcoma Cancer Research 2001 61 9 3750 3759
162. Bellido T., Ali A. A., Plotkin L. I., Fu Q., Gubrij I., Roberson P. K., Weinstein R. S., O'Brien C. A., Manolagas S. C., Jilka R. L., Proteasomal degradation of Runx2 shortens parathyroid hormone-induced anti-apoptotic signaling in osteoblasts: a putative explanation for why intermittent administration is needed for bone anabolism Journal of Biological Chemistry 2003 278 50 50259 50272
163. Ruther U., Komitowski D., Schubert F. R., Wagner E. F., c-fos expression induces bone tumors in transgenic mice Oncogene 1989 4 7 861 865
164. D'Alonzo R. C., Selvamurugan N., Karsenty G., Partridge N. C., Physical interaction of the activator protein-1 factors c-Fos and c-Jun with Cbfa1 for collagenase-3 promoter activation Journal of Biological Chemistry 2002 277 1 816 822
165. Papachristou D. J., Papachristou G. J., Papaefthimiou O. A., Agnantis N. J., Basdra E. K., Papavassiliou A. G., The MAPK-AP-1/-Runx2 signalling axes are implicated in chondrosarcoma pathobiology either independently or via up-regulation of VEGF Histopathology 2005 47 6 565 574
166. Cleton-Jansen A.-M., Anninga J. K., Briaire-de Bruijn I. H., Romeo S., Oosting J., Egeler R. M., Gelderblom H., Taminiau A. H. M., Hogendoorn P. C. W., Profiling of high-grade central osteosarcoma and its putative progenitor cells identifies tumourigenic pathways British Journal of Cancer 2009 101 11 1909 1918
167. Haydon R. C., Luu H. H., He T.-C., Osteosarcoma and osteoblastic differentiation: a new perspective on oncogenesis Clinical Orthopaedics and Related Research 2007 454 237 246
168. Mohseny A. B., Szuhai K., Romeo S., Buddingh E. P., Bruijn I. B.-D., De Jong D., Van Pel M., Cleton-Jansen A.-M., Hogendoorn P. C. W., Osteosarcoma originates from mesenchymal stem cells in consequence of aneuploidization and genomic loss of Cdkn2 Journal of Pathology 2009 219 3 294 305
169. Carpio L., Gladu J., Goltzman D., Rabbani S. A., Induction of osteoblast differentiation indexes by PTHrP in MG-63 cells involves multiple signaling pathways American Journal of Physiology 2001 281 3 E489 E499
170. Olfa G., Christophe C., Philippe L., Romain S., Khaled H., Pierre H., Odile B., Jean-Christophe D., RUNX2 regulates the effects of TNF on proliferation and apoptosis in SaOs-2 cells Bone 2010 46 4 901 910
171. Postiglione L., Di Domenico G., Montagnani S., Di Spigna G., Salzano S., Castaldo C., Ramaglia L., Sbordone L., Rossi G., Granulocyte-macrophage colony-stimulating factor (GM-CSF) induces the osteoblastic differentiation of the human osteosarcoma cell line SaOS-2 Calcified Tissue International 2003 72 1 85 97
172. Siggelkow H., Schenck M., Rohde M., Viereck V., Tauber S., Atkinson M. J., Hfner M., Prolonged culture of HOS 58 human osteosarcoma cells with 1,25- (OH)2-D3, TGF-beta, and dexamethasone reveals physiological regulation of alkaline phosphatase, dissociated osteocalcin gene expression, and protein synthesis and lack of mineralization Journal of Cellular Biochemistry 2002 85 2 279 294
173. Yang J., Zhang X., Wang W., Liu J., Insulin stimulates osteoblast proliferation and differentiation through ERK and PI3K in MG-63 cells Cell Biochemistry and Function 2010 28 4 334 341
174. Sadikovic B., Yoshimoto M., Chilton-MacNeill S., Thorner P., Squire J. A., Zielenska M., Identification of interactive networks of gene expression associated with osteosarcoma oncogenesis by integrated molecular profiling Human Molecular Genetics 2009 18 11 1962 1975